Drug recall · August 21, 2024
Timolol Maleate Ophthalmic Solution USP recall
Why: Defective container; yellow colored spike from cap lodged in the nozzle
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Timolol Maleate Ophthalmic Solution USP, 0.5%, Sterile, 5mL bottles, Rx only, Manufactured by: FDC Limited, Waluj, Aurangabad, Maharashtra, India, Distributed by: Rising Pharmaceuticals Inc, New Jersey, [NDC 64980-514-05].
- Lots / codes
Lot Number: 083J022, Expiration Date: September- 25; 083L046, Expiration date: November- 25; 083H009, Expiration date: July- 25
- Quantity
- 362,544 bottles
- Company
- FDC Limited, Aurangabad, Maharashtra State
- Distribution
- Nationwide in the US
- Initiated
- July 18, 2024 · Voluntary: Firm initiated
- Classified
- August 13, 2024
- Reported
- August 21, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Timolol
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.